Navigation Links
Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference
Date:9/7/2010

LA JOLLA, Calif., Sept. 7 /PRNewswire/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) today announced that Transdel management will present a company overview at the Rodman & Renshaw 12th Annual Healthcare Conference in New York City on Monday, September 13, 2010 at 4:05 p.m. Eastern Time.

Interested parties can access a live webcast via the Internet by visiting the Investor Relations section of the Company's Web site at http://www.transdelpharma.com.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's innovative-patented Transdel™ cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier.  Ketotransdel®, the Company's lead pain product, has successfully completed a Phase 3 clinical trial and utilizes the Transdel technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug through the skin directly into the underlying tissues where the drug exerts its well-known anti-inflammatory and analgesic effects. The Company intends to leverage its Transdel™ platform technology to expand and create a portfolio of topical products for a variety of indications.  The Company is actively pursuing partnerships with companies to expand its product portfolio for pharmaceutical and cosmetic/cosmeceutical products.  For more information, please visit http://www.transdelpharma.com.

Safe Harbor Statement

The Company cautions you that the statements included in this press release that are not a description of historical facts are forward-looking state
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
2. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
3. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
4. Transdel Pharmaceuticals to Present at Two Investor Conferences
5. Transdel Pharmaceuticals Reports First Quarter 2010 Results
6. Transdel Pharmaceuticals Enters into License Agreement with Jan Marini Skin Research for Cosmeceutical Product
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
8. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
9. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
10. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
11. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... PLAINSBORO, N.J. (PRWEB) October 20, 2014 ... that the Sidney Kimmel Cancer Center at Thomas ... program. , Through the Strategic Alliance Partnership ... and OncLive will collaborate to raise awareness of ... cancer treatment, and other projects. Clinicians and other ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Local veterinary ... in an investigational study of donor stem cells for ... stem cell therapy and has performed clinical stem cell ... study is to determine if a single injection of ... joints can help reduce pain and inflammation in the ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The ... ABIM will take place at the Congress ... 2014 is now available at http://www.abim.ch ... and organizations from all over the globe ... the latest products and developments on the ...
Breaking Biology Technology:Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Aerolase, the manufacturer of,medical aesthetic lasers, announced today ... of Sanders Morris Harris Group (Nasdaq: SMHG ... to fund expansion into,new markets., The additional ... sales channel expansion into the market of about ...
... Sept. 19 /Xinhua-PRNewswire/ -- Latest agricultural news from,tootoo.com ... are welcoming the new,booming trends of Organic Farming ... ), Organic farming and organic foods have ... with domestic and overseas demands for organic,food, organic ...
... Mass., Sept. 19 PLC Systems Inc.,(Amex: PLC ... of failure to,meet listing qualifications dated September 17, 2008 ... Exchange. The notice,stated that the Company was not in ... the Company,s shareholders, equity was less,than $4,000,000 as of ...
Cached Biology Technology:Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion 2tootoo.com: China's Farmers Welcome the New Trend of Organic Farming 2PLC Systems Receives Delisting Notice From American Stock Exchange 2
(Date:10/18/2014)... sample of patients with undiagnosed, suspected genetic conditions, a ... a higher molecular diagnostic yield than traditional molecular diagnostic ... . The study is being released to coincide with ... Exome sequencing, which sequences the protein­coding region of the ... present in a cell or organism), has been rapidly ...
(Date:10/17/2014)... available in German . ... every day in order to reproduce? And why are there ... of the latest issue of the research journal Molecular ... biologist Steven Ramm from Bielefeld University Bielefeld has compiled this ... unusual for a female to copulate with several males in ...
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Genetic variations in DNA repair patterns may increase risk ... it by as much as 77 percent, depending on the ... 15, 2009, issue of Clinical Cancer Research , a ... Pancreatic cancer is often identified in late stages, and thus ...
... 2008) New data released today by the Wildlife ... Parks (DWNP) reveals that a population of endangered Asian ... largest in Southeast Asia. WCS and DWNP researchers estimate ... Negara National Park a 4,343 square kilometer (1,676 ...
... crops, including corn, rapeseed and wheat, have been overestimated ... countries need to reset their expectations of agricultural biofuels ... a study led by Matt Johnston and Tracey Holloway ... Studies and Jon Foley of University of Minnesota, which ...
Cached Biology News:Jumbo-sized discovery made in Malaysia 2Nations that sow food crops for biofuels may reap less than previously thought 2Nations that sow food crops for biofuels may reap less than previously thought 3
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Cytofix Buffer 100 mls...
Perm/Wash Buffer 250 Tests...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Biology Products: